Verified Beauty Data

Ingredient dossier Nº 016 / The verified record

Ceramides

CERAMIDE NP · CosIng 75318 · also ceramide AP, skin lipids, ceramide 2, ceramide 3

Effective concentration, the pH it needs, how the derivatives compare, stability in the bottle, and the open questions — every scientific claim on this page links to its source.

Editorial verdict / Social intelligence

Qualified yes Ingredient dossier

The skin's own repair lipid — foundational, not flashy, and most effective when the formula includes cholesterol and free fatty acids alongside the ceramides. 1

Beauty benefit
Ceramides are the skin's own structural lipid — they make up roughly 40–50% of the stratum corneum lipid matrix and physically hold the barrier together. Topical ceramide products replenish depleted lipid reserves, reducing transepidermal water loss, calming reactive skin, and restoring the physical seal that keeps irritants out. They are the foundational repair ingredient for eczema, barrier-damaged skin, and chronically dry or sensitized complexions. They do not brighten, fight acne, or stimulate collagen — their job is structural barrier restoration, and they do it exceptionally well.
Does it work
Yes, with one important caveat: ceramide alone is not the full mechanism. Foundational research by Man, Feingold, and Elias (1993–1996) established that the skin barrier requires all three lipid classes — ceramide, cholesterol, and free fatty acids — in approximately equimolar proportions to repair properly. Applying ceramide in isolation actually delays barrier recovery compared to the complete lipid trio. Well-formulated ceramide products pair ceramide with the full set of co-lipids, and these have demonstrated statistically significant TEWL reduction, SCORAD improvement in atopic dermatitis, and improved hydration in multiple clinical trials. The ingredient is safe, well-tolerated, and clinically validated — but the formulation context (are co-lipids present?) determines whether the label claim translates to real benefit. See the science below →

Consensus strength

Strong

Strong scientific and dermatological consensus that topical ceramide-containing formulations restore barrier function and reduce TEWL, with validated clinical evidence across multiple randomized and observational trials in atopic dermatitis populations. The 'qualified' holy_grail reflects two honest limits: (1) ceramide alone without co-lipids (cholesterol, free fatty acids) produces inferior barrier recovery — a foundational finding that most beauty editorial ignores; (2) depth of integration of topically applied ceramides into the native lamellar bilayer has not been confirmed via structural characterization in vivo. In healthy skin without barrier disruption, the functional benefit is real but more modest than in eczema, reactive, or aged skin.

01 / What it does

What it does

Ceramides are a family of sphingolipids that make up roughly 40–50% of the stratum corneum lipid matrix by weight. Together with cholesterol (~25%) and free fatty acids (~15%), they self-assemble into lamellar bilayers in the extracellular spaces between corneocytes. This ordered lipid architecture is the primary physical barrier against transepidermal water loss (TEWL) and percutaneous entry of irritants and allergens. Twelve ceramide subclasses have been described in human skin, designated by their sphingoid base (non-hydroxy N, alpha-hydroxy A, omega-hydroxy EO) and fatty acid head group (phytosphingosine P, sphingosine S, dihydrosphingosine dS). Ceramide NP (ceramide 2) and ceramide NS (ceramide 3) are the most abundant. Ceramide EOP, though only about 10% of total mass, is critical for lamellar organization via its esterified linoleic acid. Ceramides are biosynthesized in the epidermis: glucosylceramides packed in lamellar bodies are secreted at the granular-to-corneum transition and hydrolyzed by beta-glucocerebrosidase to free ceramides that integrate into the lamellar sheets.

02 / Effective concentration

What percentage actually works

Effective range

0.001–1%

Ceramides are used at very low concentrations in finished cosmetic formulations (as low as 0.001% in some products up to ~1% in barrier repair creams), reflecting their high molecular weight, lipophilicity, and the fact that they function via integration into the lipid bilayer rather than as pharmacologically dosed actives. The molar ratio to co-lipids (cholesterol and free fatty acids) is often more important than absolute ceramide concentration.

CIR safety data show ceramide 3 used at 0.2% in lipstick and ceramide 2 at 0.2% in eye lotion; body-spray concentrations as low as 0.001% have been reported. Barrier repair formulations like the 3:1:1 ceramide:cholesterol:fatty acid ratio used in clinical trials represent a physiologic-ratio approach rather than a specific ceramide wt% target. There is no single published dose-response curve for topical ceramide efficacy in humans analogous to the pH/concentration curve established for L-ascorbic acid. The ratio of ceramide to cholesterol to free fatty acid is better-studied than absolute ceramide percentage as a formulation parameter.

  • Study A ceramide-dominant, physiologic lipid-based topical emulsion with a 3:1:1 ratio of ceramides:cholesterol:free fatty acids improved atopic dermatitis signs and symptoms in a 50-center, open-label interventional study of 207 patients. 15
  • CIR Ceramide 3 is used at 0.2% in lipstick and ceramide 2 at 0.2% in eye lotion; ceramide 3 in body and hand sprays at a maximum of 0.001% — illustrating the wide concentration range in commercial products. 17

One honest caveat No published dose-response curve for ceramide concentration in topical products analogous to the Pinnell percutaneous absorption data for L-ascorbic acid. Optimal wt% for topical ceramide formulations is not defined in the peer-reviewed literature.

03 / pH requirement

The pH it needs

Target pH

Not a primary determinant

Unlike L-ascorbic acid, ceramides do not have a critical pH requirement for skin penetration. They are lipophilic molecules that integrate into the stratum corneum lipid bilayer directly. The critical formulation variable for ceramides is the molar ratio of ceramide to cholesterol to free fatty acid (physiologic target: ~1:1:1 to 3:1:1 ceramide:cholesterol:FFA) and the lamellar organization of the delivery vehicle. Aqueous formulations must solubilize ceramides with appropriate emulsifiers, and the overall vehicle architecture — not pH — determines how well ceramides integrate into the stratum corneum lipid matrix. Typical cosmetic formulation pH of 4.5–6.5 is appropriate for skin compatibility but is not a ceramide-specific requirement.

  • Study The key determinant of ceramide barrier function is the molar ratio of ceramide, cholesterol, and free fatty acid — not pH. Equimolar mixtures allow normal barrier recovery; omitting any one lipid impairs it. 3

04 / Derivative ladder

How the derivatives compare

Every derivative trades a measure of proven activity for stability or gentleness. Skin conversion is the question that matters — a more stable molecule only helps if your skin can turn it back into the active form.

  1. Ceramide NP (Ceramide 2)

    CERAMIDE NP

    Non-hydroxy fatty acid / phytosphingosine base. One of the two most abundant ceramide subclasses in human stratum corneum. INCI anchor for this family. Most commonly used ceramide in cosmetic formulations. Direct structural analog of an abundant native skin lipid.

    • Study Ceramide NP and ceramide NS are the most abundant ceramide subclasses in human stratum corneum; ceramide NP (ceramide 2) and ceramide AP (ceramide 6-II) are among the 12 recognized ceramide classes defined by sphingoid base and fatty acid pairing. 10

  2. Ceramide AP (Ceramide 6-II)

    CERAMIDE AP

    Alpha-hydroxy fatty acid / phytosphingosine base. Also abundant in stratum corneum. The alpha-hydroxy fatty acid confers slightly different packing geometry in the lamellar bilayer vs. the non-hydroxy N series. Used in cosmetic delivery systems targeting penetration into the stratum corneum interstices.

    • Study Ceramide AP (CER [AP]) is an integral component of the stratum corneum lipid matrix; microemulsion delivery systems have been designed specifically to solubilize ceramide AP and enhance its penetration into the stratum corneum. 19

  3. Ceramide EOP

    CERAMIDE EOP

    Omega-esterified / phytosphingosine base, with linoleic acid esterified at the omega position of the fatty acid chain. Represents ~10% of total ceramide mass but is disproportionately important for lamellar bilayer organization. Linoleic acid deficiency results in a structurally defective barrier. This subclass is the metabolic product whose deficiency is associated with scaly, barrier-disrupted skin in essential fatty acid deficiency models.

    • Study The omega-esterified ceramide subclasses (EOS, EOH, EOP) represent about 10% of total ceramide mass but are critical for normal lamellar membrane organization in the stratum corneum. 10

  4. Pseudoceramide (synthetic ceramide analog)

    various — e.g. CETYL PG HYDROXYETHYL PALMITAMIDE

    Synthetic structural analogs of ceramide designed to mimic biological function without requiring extraction from natural sources (bovine brain, plant, or fermentation). Pseudoceramides can penetrate the stratum corneum and improve barrier function; some trigger endogenous ceramide synthesis in keratinocytes. They avoid the BSE/bovine CNS sourcing concern flagged by the CIR panel for animal-derived ceramides.

    • Study Daily application of pseudoacylceramide immediately after barrier disruption significantly prevented the marked elevation of TEWL seen in untreated controls, demonstrating effective barrier recovery capability. 12

  5. Cholesterol + Free Fatty Acids (the lipid trio concept)

    CHOLESTEROL; various free fatty acids (PALMITIC ACID, STEARIC ACID, LINOLEIC ACID)

    Not ceramide derivatives, but functionally inseparable co-lipids. The physiologic stratum corneum ratio of ~1:1:1 ceramide:cholesterol:free fatty acid by moles is the defining insight from the Elias/Man/Feingold line of work. Barrier repair formulations providing ceramide alone without cholesterol and free fatty acids produce inferior recovery. Ceramide-dominant products at a 3:1:1 ceramide:cholesterol:FFA ratio have been validated in clinical atopic dermatitis trials.

    • Study Exogenous lipid mixtures applied to acetone-treated murine skin show that complete mixtures of all three key stratum corneum lipids allow barrier recovery, while single-lipid or two-lipid applications delay recovery, demonstrating the necessity of the full lipid trio. 2

05 / Stability & storage

Stability in the bottle

Ceramides are chemically stable lipids — they do not oxidize rapidly or degrade at low pH the way water-soluble actives like L-ascorbic acid do. Their primary formulation challenge is solubilization: ceramides are highly hydrophobic and require elevated temperature (often 70–80°C) and appropriate emulsifiers or carrier solvents to disperse into aqueous creams. Once dispersed, they are physically stable. Photodegradation is not a primary concern. The UV exposure concern relevant to skin is that broad-spectrum UV irradiation can alter the stratum corneum ceramide profile, reducing total ceramides and shifting subclass ratios — an argument for using ceramide-containing formulations as part of a sun-protective routine. The main stability risk in finished products is physical separation (emulsion break) rather than chemical degradation of the ceramide molecule itself.

In practice Buy it in an opaque, airless, or amber container, store it cool and out of the light, and treat a colour shift toward orange or brown as the signal to replace it — the molecule is telling you it has already oxidised.

06 / How to use it

How to actually use Ceramides

When
AM/PM — Last steps, or built into your moisturizer.
Pairs well with
niacinamide, hyaluronic acid, cholesterol + fatty acids.
Apply apart from
Nothing major — it layers comfortably with most actives.
What to look for
A moisturizer that pairs ceramides with cholesterol and fatty acids.
Heads-up
Universally tolerated; the barrier-repair workhorse that lets you use actives more comfortably.

Practical guidance for routine placement — not a substitute for a dermatologist’s advice for your skin.

07 / The database

Ceramides: measured product rankings coming soon

Ranked by $ per gram of active — what the working ingredient actually costs you, not the sticker price. Rows we have reviewed in full link through; the rest are data points from the same crawl.

Buy CeraVe on Amazon $17.06 Top-ranked pick · affiliate link

No measured products yet — this active's price-per-gram rankings will appear here as products are added.

In the meantime, see how to use Ceramides and what to look for on a label .

Contains it, but doesn't disclose a percentage: CeraVe CeraVe Moisturizing Cream ; SkinCeuticals SkinCeuticals Triple Lipid Restore 2:4:2

08 / Safety

Is it safe?

Reviewed by the Cosmetic Ingredient Review — safe as used

Safe as used — Final Report (2020). The CIR Expert Panel for Cosmetic Ingredient Safety concluded that ceramides are safe in cosmetics at present practices of use and concentration. IMPORTANT CAVEAT: the Panel specified that this conclusion assumes ceramide ingredients are NOT derived from bovine central nervous system tissues (BSE risk). Plant-derived, fermentation-derived, and synthetic pseudoceramides are not subject to this restriction.

Ceramides are endogenous human skin lipids with an excellent tolerability profile. No significant sensitization, irritation, or phototoxicity signals were identified in the CIR review. They are physiologically compatible with human skin chemistry. No carcinogenicity concerns. The primary formulation risks are emulsion stability and uniform dispersion rather than intrinsic toxicity of the ceramide molecule.

  • CIR The CIR Expert Panel for Cosmetic Ingredient Safety concluded that ceramides are safe in cosmetics at current practices of use and concentration, provided they are not derived from bovine central nervous system tissues. 17

09 / The limits of the evidence

What we don't know yet

Most of what you read about this ingredient is stated with more certainty than the evidence earns. Here is exactly where the record thins out — so you can weigh the claims above for yourself.

  1. Most clinical evidence for ceramide efficacy comes from multi-lipid formulations (ceramide + cholesterol + free fatty acids in a defined ratio). Isolating the contribution of ceramide specifically, versus cholesterol or free fatty acids, is not established by independent randomized controlled trials.
  2. No published dose-response curve for ceramide concentration in topical products analogous to the Pinnell percutaneous absorption data for L-ascorbic acid. Optimal wt% for topical ceramide formulations is not defined in the peer-reviewed literature.
  3. The claim that topically applied ceramides 'integrate' into the lamellar bilayer in the same organized fashion as endogenously synthesized ceramides has not been directly demonstrated in human in vivo studies using structural characterization (e.g., small-angle X-ray scattering of biopsied stratum corneum post-treatment).
  4. Head-to-head trials comparing specific ceramide subclasses (NP vs. AP vs. EOP) in matched formulations are not in the published literature; multi-subclass marketing claims outpace comparative evidence.
  5. Pseudoceramide vs. true ceramide head-to-head comparative clinical trials are absent from the peer-reviewed record.
  6. Long-chain base distribution and chain-length diversity of topically applied ceramides versus endogenous ceramides has not been characterized to verify bioequivalence in the lamellar structure.
  7. Large-scale long-term trials on ceramide-containing products for prevention of barrier disruption in healthy skin (rather than treatment of compromised barrier) are lacking.
  8. Most atopic dermatitis trials of ceramide-containing formulations are open-label, non-blinded, or used multi-component products — making attribution of benefit to ceramides specifically difficult.

10 / What people say

What formulators and users say

What works

  • Common Directly replenishes the skin's primary structural lipid — ceramides make up roughly half the intercellular matrix of the stratum corneum and are the core material of barrier integrity 11416
    the barrier operates through lipid enriched lamellar membranes located in the stratum corneum's extracellular spaces, with a composition of approximately 50% ceramides, 25% cholesterol, and 15% fatty acids Study
  • Common Clinically validated for atopic dermatitis — ceramide-dominant formulations produce significant SCORAD reduction and TEWL improvement in both pediatric and adult eczema 459
    applying this barrier-repair emollient alongside standard treatments led to significant improvements in disease severity scores within three weeks Study
  • Common Topical ceramides penetrate and are retained more readily in dry or barrier-compromised skin — the ingredient works hardest exactly where it is most needed 1110
    In the dry skin model group, the intensity of externally applied ceramide increased significantly from 0 minute to 12 hours after application, whereas normal skin showed no significant change Study
  • Common Ceramide levels naturally decline with age — replenishing them topically addresses a real physiological deficit, making ceramides one of the most mechanistically justified moisturizer ingredients for mature skin 1610
    The body's natural production of ceramides gradually declines with age, leading to drier and less supple skin Editorial
  • Common Exceptionally safe and well-tolerated — the CIR Expert Panel confirmed ceramides are safe at current cosmetic use concentrations, with no irritation, sensitization, or phototoxicity signals; endogenous to human skin 8
    ceramides were safe in cosmetics in the present practices of use and concentration described in this safety assessment Study
  • Common Hydration effects last up to 24 hours after application — a durable practical benefit over basic humectants that require re-application for sustained moisture retention 16
    Ceramide cream has been found to increase skin hydration and reduced water loss, with the effects lasting for a full 24 hours after application Editorial

What to know

  • Common Most ceramide products do not disclose their ceramide-to-cholesterol-to-fatty-acid ratio — and ceramide alone without co-lipids delays rather than accelerates barrier recovery; the label claim does not guarantee the mechanism 23
    complete mixtures of ceramide, fatty acid, and cholesterol allowed normal barrier recovery, while individual components or partial combinations did not Study
  • Some Very expensive products often list ceramides far down the ingredient deck — at concentrations as low as 0.001%, the label claim is technically true but functionally trivial 8
    ceramide 3 in body and hand sprays at a maximum of 0.001% — illustrating the wide concentration range in commercial products Study
  • Some Ceramides are difficult to formulate — high molecular weight and extreme hydrophobicity require careful emulsification at elevated temperature; an unstable emulsion may deliver ceramide unevenly or not at all 1
    the critical formulation variable for ceramides is the molar ratio of ceramide to cholesterol to free fatty acid and the lamellar organization of the delivery vehicle — not pH Study
  • Some Atopic dermatitis patients need ceramides most, but in this population both the quantity of ceramides and the surface area they cover are reduced — recovery requires sustained consistent use rather than a quick fix 167
    People with this condition not only have fewer ceramides, but the ones they do have cover less of the skin's surface area Editorial
  • Some Marketing claims around multiple ceramide 'types' (NP, AP, EOP, NS, etc.) outpace clinical evidence — no head-to-head trials confirm that multi-subclass blends outperform single-ceramide formulations with the correct co-lipid ratio 141
    works even better when combined with its pal, Ceramide 1 Editorial

What you'd only know from the reviews

  • Ceramide alone does not repair the barrier optimally — and in fact delays recovery versus doing nothing. The Man/Feingold/Elias 1993–1996 work established that the barrier needs ceramide, cholesterol, and free fatty acids in approximately equimolar proportions. A product listing only ceramides without cholesterol and fatty acids is mechanistically inferior to a full-lipid-trio formulation. This is the single most important and most ignored fact in ceramide marketing. 23

  • The ceramide deficit in atopic dermatitis is enzyme-driven, not simply wear-related: overexpression of sphingomyelin deacylase hijacks the ceramide biosynthesis pathway and produces ceramide-deficient by-products instead of skin-protective ceramides. This means topical ceramide replenishment addresses a real biochemical deficit — not just surface dryness — which explains why ceramide products outperform ordinary occlusives in eczema-prone skin. 76

  • UV exposure actively dismantles your ceramide profile. Broad-spectrum UV radiation alters ceramide subclass ratios in the stratum corneum and reduces the very-long-chain acyl moieties critical for lamellar organization. This makes ceramide-containing products relevant not just for winter dryness or eczema, but as daily support for anyone with significant sun exposure — a connection almost never communicated in product marketing. 12

  • Pseudoceramides (synthetic ceramide analogs like cetyl PG hydroxyethyl palmitamide) work for barrier repair and research shows they prevent TEWL elevation after surfactant damage. They also avoid the BSE sourcing concern the CIR flagged for animal-derived ceramides. Many affordable products use synthetic analogs that the literature suggests perform equivalently — the label distinction between 'ceramide' and 'pseudoceramide' is rarely surfaced in consumer marketing. 138

  • Dry and barrier-compromised skin absorbs externally applied ceramides significantly better than healthy intact skin. The products feel most dramatic and deliver the most measurable benefit on skin that is most damaged. If a ceramide product seems underwhelming on healthy skin, that may simply mean the barrier does not need the repair — not that the ingredient fails. 11

  1. 1 Study Role of lipids in the formation and maintenance of the cutaneous permeability barrier — Feingold & Elias 2014
  2. 2 Study Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin — Man, Feingold, Elias 1993
  3. 3 Study Optimization of physiological lipid mixtures for barrier repair — Man, Feingold, Thornfeldt, Elias 1996
  4. 4 Study Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity 2002
  5. 5 Study Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis — Kircik, Del Rosso, Aversa 2011
  6. 6 Study Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? — Imokawa et al. 1991
  7. 7 Study High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis — Hara et al. 2000
  8. 8 Study Safety Assessment of Ceramides as Used in Cosmetics — CIR Expert Panel (Burnett et al.) 2020
  9. 9 Study Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis — Sugarman & Parish 2009
  10. 10 Study Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review — Kono, Miyachi, Kawashima 2021
  11. 11 Study Comparison of ceramide retention in the stratum corneum between dry skin and normal skin using fluorescent imaging — Aoki et al. 2019
  12. 12 Study Alteration to the Skin Ceramide Profile Following Broad-Spectrum UV Exposure — Barresi et al. 2022
  13. 13 Study Characterization of surfactant-induced skin damage through barrier recovery induced by pseudoacylceramides — Takagi et al. 2005
  14. 14 Editorial Ceramide NP — INCIDecoder ingredient profile 2024
  15. 15 Editorial Ceramide AP — INCIDecoder ingredient profile 2024
  16. 16 Editorial Ceramides for Skin: Benefits, Side Effects, and Product Recommendations — Derm Collective 2024

11 / Questions

Frequently asked

What do ceramides actually do in skincare?
Ceramides are the dominant lipid class in the outermost skin layer (stratum corneum), making up ~40–50% of its lipid mass. They self-assemble with cholesterol and free fatty acids into lamellar bilayer sheets in the spaces between corneocytes, forming a waterproof physical barrier that reduces TEWL and blocks entry of irritants. Topical ceramides replenish this lipid matrix when it has been depleted by surfactants, detergents, harsh weather, age, or inflammatory skin conditions. They do not stimulate collagen, treat acne, or inhibit pigment — their mechanism is structural barrier reinforcement. 113
Why do products say 'ceramide NP, AP, EOP' — do you need all the types?
The human stratum corneum contains 12 recognized ceramide subclasses. Ceramide NP and AP are the most abundant; ceramide EOP is ~10% of mass but critical for lamellar organization via its esterified linoleic acid moiety. Consumer evidence that multi-subclass mixtures are meaningfully superior to single ceramide types in topical formulations has not been established in head-to-head clinical trials. The evidence from the Elias/Man/Feingold research shows the ceramide:cholesterol:free-fatty-acid ratio matters more than which specific ceramide subclass is used. Multi-subclass labeling may reflect manufacturing practice (plant-derived sphingolipid extracts naturally contain mixed species) as much as evidence-based targeting. 1032
Do ceramides alone repair the skin barrier?
Not optimally. The foundational research by Man, Feingold, and Elias (1993, 1996) established that barrier recovery in perturbed skin requires all three stratum corneum lipids — ceramide, cholesterol, and free fatty acid — in approximately equimolar proportions. Applying ceramide alone, or missing any one of the trio, delays barrier recovery compared to the equimolar mixture. Barrier-repair products formulated with all three lipid classes have shown clinical efficacy in atopic dermatitis trials; products containing only ceramide have a weaker evidence base. This is arguably the most important and underappreciated finding in ceramide science. 327
Why do atopic dermatitis patients need ceramide-containing moisturizers?
Ceramide levels in the stratum corneum are significantly reduced in atopic dermatitis — both in lesional and non-lesional skin compared to healthy controls. Imokawa et al. (1991) first demonstrated this, finding ceramide 1 (ceramide EOS) was most severely depleted. The mechanism involves overexpression of sphingomyelin deacylase, an enzyme that shunts ceramide precursors away from ceramide synthesis to lysoform by-products (Hara et al., 2000). This deficit impairs barrier function, increases TEWL, and allows allergen entry — contributing to the itch-scratch cycle. Ceramide-dominant barrier repair formulations have demonstrated statistically significant improvements in SCORAD and TEWL in pediatric and adult AD trials. 15714
Do ceramides decline with age?
Yes. Denda et al. (1993) showed that stratum corneum sphingolipid content changes significantly with age and sex, with reductions contributing to the xerosis (dry skin) commonly seen in elderly individuals. Topical approaches to increasing ceramide levels in aged skin have been explored, including bacterial sphingomyelinase application (Di Marzio et al., 2008), which demonstrated measurable increases in skin ceramide levels after short-term topical treatment in aged subjects. 913
Is topical ceramide absorbed into the skin?
Research using fluorescent-labeled ceramides shows that externally applied ceramide does penetrate the stratum corneum, with greater retention in dry skin than normal skin — consistent with the idea that dry/barrier-compromised skin is more permeable to lipid supplementation. However, the depth of integration and whether topically applied ceramides fully replicate the lamellar organization of endogenous ceramides is not fully established in human in vivo studies. Many positive clinical outcomes attributed to 'ceramide' products come from multi-lipid formulations (ceramide + cholesterol + free fatty acids), making it difficult to attribute efficacy to ceramide delivery specifically. 1618
What is the difference between 'ceramide' and 'pseudoceramide' in ingredient lists?
True ceramides (e.g., CERAMIDE NP, CERAMIDE AP) are sphingolipid molecules identical or closely analogous to those naturally present in human skin. They may be derived from animal sources (bovine brain — now disfavored due to BSE risk), plant sources (wheat, rice), or fermentation/biotech. Pseudoceramides are synthetic structural analogs (e.g., cetyl PG hydroxyethyl palmitamide) designed to mimic ceramide function in the skin without being true sphingolipids. They avoid BSE sourcing concerns and can be manufactured at scale. Research shows pseudoceramides improve barrier function and reduce TEWL, but head-to-head comparative trials against true ceramides in equivalent formulations are sparse. 1217

→ / Related

More from the verified record

12 / References

Sources

20 references · verified 2026-06-13
  1. 1

    Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?

    G Imokawa, A Abe, K Jin, Y Higaki, M Kawashima, A Hidano · J Invest Dermatol 96(4):523-6 · 1991

  2. 2

    Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin

    M Q Man, K R Feingold, P M Elias · Archives of Dermatology 129(6):728-38 · 1993

  3. 3

    Optimization of physiological lipid mixtures for barrier repair

    M Man MQ, K R Feingold, C R Thornfeldt, P M Elias · J Invest Dermatol 106(5):1096-101 · 1996

  4. 4

    Ceramide and cholesterol composition of the skin of patients with atopic dermatitis

    A Di Nardo, P Wertz, A Giannetti, S Seidenari · Acta Derm Venereol 78(1):27-30 · 1998

  5. 5

    High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis

    J Hara, K Higuchi, R Okamoto, M Kawashima, G Imokawa · Journal of Investigative Dermatology 115(3):406-13 · 2000

  6. 6

    Lamellar body secretory response to barrier disruption

    G K Menon, K R Feingold, P M Elias · J Invest Dermatol 98(3):279-89 · 1992

  7. 7

    Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity

    Sarah L Chamlin, Jack Kao, Ilona J Frieden, Mary Y Sheu, Ashley J Fowler, Joachim W Fluhr, Mary L Williams, Peter M Elias · Journal of the American Academy of Dermatology 47(2):198-208 · 2002

  8. 8

    Human epidermal glucosylceramides are major precursors of stratum corneum ceramides

    Sumiko Hamanaka, Mariko Hara, Hiroyuki Nishio, Fujio Otsuka, Akemi Suzuki, Yoshikazu Uchida · Journal of Investigative Dermatology 119(2):416-23 · 2002

  9. 9

    Age- and sex-dependent change in stratum corneum sphingolipids

    M Denda, J Koyama, J Hori, I Horii, M Takahashi, M Hara, H Tagami · Arch Dermatol Res 285(7):415-7 · 1993

  10. 10

    Investigation of the molecular structure of the human stratum corneum ceramides [NP] and [EOS] by mass spectrometry

    A Hinder, C E H Schmelzer, A V Rawlings, R H H Neubert · Skin Pharmacol Physiol 24(3):127-35 · 2011

  11. 11

    Role of lipids in the formation and maintenance of the cutaneous permeability barrier

    Kenneth R Feingold, Peter M Elias · Biochim Biophys Acta 1841(3):280-94 · 2014

  12. 12

    Characterization of surfactant-induced skin damage through barrier recovery induced by pseudoacylceramides

    Yutaka Takagi, Hidemi Nakagawa, Kazuhiko Higuchi, Genji Imokawa · Dermatology 211(2):128-34 · 2005

  13. 13

    Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus

    L Di Marzio, B Cinque, F Cupelli, C De Simone, M G Cifone, M Giuliani · International Journal of Immunopathology and Pharmacology 21(1):137-43 · 2008

  14. 14

    Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis

    Jeffrey L Sugarman, Lawrence Charles Parish · J Drugs Dermatol 8(12):1106-11 · 2009

  15. 15

    Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis

    Leon H Kircik, James Q Del Rosso, Daniel Aversa · J Clin Aesthet Dermatol 4(3):34-40 · 2011

  16. 16

    Comparison of ceramide retention in the stratum corneum between dry skin and normal skin using animal model with fluorescent imaging method

    Miku Aoki, Kazuhiro Ogai, Masato Kobayashi, Takeo Minematsu, Toshio Nakatani, Mayumi Okuwa, Hiromi Sanada, Junko Sugama · Skin Research and Technology 25(2):158-164 · 2019

  17. 17

    Safety Assessment of Ceramides as Used in Cosmetics

    Christina L Burnett, Ivan J Boyer, Wilma F Bergfeld, Donald V Belsito, Ronald A Hill, Curtis D Klaassen, Daniel C Liebler, James G Marks Jr, Ronald C Shank, Thomas J Slaga, Paul W Snyder, Lillian J Gill, Bart Heldreth · International Journal of Toxicology 39(3_suppl):5S-25S · 2020

  18. 18

    Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review

    Takeshi Kono, Yoshiki Miyachi, Makoto Kawashima · J Dermatol 48(12):1807-1816 · 2021

  19. 19

    Polyglycerol fatty acid ester surfactant-based microemulsions for targeted delivery of ceramide AP into the stratum corneum: formulation, characterisation, in vitro release and penetration investigation

    Fitsum F Sahle, Hendrik Metz, Johannes Wohlrab, Reinhard H H Neubert · European Journal of Pharmaceutics and Biopharmaceutics 82(1):139-50 · 2012

  20. 20

    Alteration to the Skin Ceramide Profile Following Broad-Spectrum UV Exposure

    Rebecca Barresi, Hawasatu Dumbuya, I-Chien Liao, Ying Chen, Xi Yan, Janet Wangari-Olivero, Nada Baalbaki, Stephen Lynch, Patricia Brieva, Miao Wang, Qian Zheng, Charbel Bouez · J Drugs Dermatol 21(1):77-85 · 2022